(Press-News.org) The management of Helicobacter pylori (H. pylori), a globally prevalent gastric pathogen, has long been centered on its eradication to prevent peptic ulcers, gastric malignancies, and related gastrointestinal complications. However, a newly published meta-analysis in eGastroenterology raises a crucial clinical dilemma: Could the treatment itself, intended to heal, paradoxically increase the risk of reflux oesophagitis (RE)? Led by Prof. Mingxin Zhang and colleagues from Xi'an Medical University and The First Affiliated Hospital of Xi'an Medical University, this comprehensive systematic review and meta-analysis synthesizes findings from 30 studies, offering a clearer picture of the association between H. pylori eradication and RE development or recurrence.
The authors conducted a systematic search across PubMed, Embase, Web of Science, and the Cochrane Library up to December 2024. Eligible studies were randomized controlled trials (RCTs) or prospective cohort studies evaluating the occurrence or recurrence of RE following H. pylori eradication. In total, 16 RCTs and 14 prospective cohort studies were included. The meta-analysis was conducted using Review Manager 5.4, and subgroup analyses explored the role of age, region, underlying diseases, and duration of follow-up. The study was registered with PROSPERO (CRD42024529321) and adhered to PRISMA guidelines.
Key Findings
(1) Overall Increased Risk After Eradication
In the RCTs, patients who underwent H. pylori eradication had a 39% higher risk of developing or experiencing recurrence of RE compared to those in placebo groups. This result was statistically significant and showed low heterogeneity (I²=28%), strengthening its reliability. Conversely, the pooled data from prospective cohort studies did not reach statistical significance, and heterogeneity was high (I²=78%), indicating potential confounding factors.
(2) Age-Based Subgroup Analysis
Subgroup analysis by age revealed no statistically significant increase in RE risk across young (≤40 years), middle-aged (40–60 years), or elderly (≥60 years) groups. However, most data came from middle-aged patients, where the RR remained elevated but non-significant in both RCTs and cohort studies, suggesting a potential trend.
(3) Impact of Underlying Disease
Among patients with peptic ulcer disease (PUD), eradication was significantly associated with a higher RE risk in RCTs, but not in cohort studies. In contrast, no significant difference was found among patients with GERD, RE, or dyspepsia across both study designs, although dyspepsia patients in cohort studies showed a notable increase.
(4) Regional Differences
Geographic variations in risk were modest. RCTs showed elevated but not statistically significant risk increases in Asia, the Americas, and Europe. Among cohort studies, Asian populations demonstrated a significant risk elevation, whereas European populations did not. These findings point to potential environmental, genetic, or dietary modifiers.
(5) Follow-up Duration Matters
Time emerged as a critical factor. In RCTs with >1 year follow-up, the risk of RE was significantly increased, suggesting a time-dependent effect of eradication. Similarly, long-term follow-up cohort studies showed higher RE incidence, whereas short-term data did not show a difference.
Clinical Implications
The findings call for a nuanced approach to H. pylori management. While eradication remains essential in preventing ulcers and gastric malignancies, clinicians should weigh the potential trade-offs, especially for patients without clear indications for therapy. In practice, individual factors such as age, existing gastrointestinal conditions, and regional background should inform clinical decisions. Moreover, monitoring patients post-eradication for reflux symptoms may be prudent, particularly in those with predisposing factors or prior RE episodes.
The authors acknowledge several limitations: (1) High heterogeneity in cohort studies due to variable designs and populations; (2) Exclusion of non-English/Chinese studies and unpublished data, introducing potential selection bias; (3) Inability to assess the severity and timing of RE symptoms post-eradication due to lack of consistent reporting; (4) The reliance on infection status at final follow-up, not the initial treatment regimen, may introduce misclassification bias. Despite these issues, the large dataset and consistent findings from RCTs enhance confidence in the results.
In conclusion, this landmark meta-analysis underscores that H. pylori eradication therapy—though beneficial in many respects—may elevate the risk of reflux oesophagitis, particularly with long-term follow-up. The effect is modified by region, age, and baseline disease but remains clinically meaningful. Physicians are urged to personalize H. pylori treatment strategies and consider patient-specific risks for RE before initiating eradication therapy.
See the article:
Li A, Zhang Y, Chen K, et al. Association between infection of Helicobacter pylori and the risk of reflux oesophagitis occurrence or recurrence: a systematic review and meta-analysis. eGastroenterology 2025;3:e100121. doi:10.1136/egastro-2024-100121
About eGastroenterology
eGastroenterology is a new, open-access, and open peer-reviewed BMJ Journal, which focuses on basic, clinical, translational, and evidence-based medicine research in all areas of gastroenterology (including hepatology, pancreatology, esophagology, and gastrointestinal surgery). eGastroenterology is now indexed by PubMed, Scopus, CAS, DOAJ, Dimensions, OpenAlex, ROAD, and COPE, with more to come!
For more information, please visit: egastroenterology.bmj.com and follow us on Twitter (@eGastro_BMJ).
Sign-up to Email Alerts for eGastroenterology: https://emails.bmj.com/k/Bmj/jausu/egastroenterology
END
The University of California San Diego's Altman Clinical and Translational Research Institute (ACTRI) has received a seven-year, $80 million Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health.
This prestigious award is the fourth consecutive CTSA awarded to the institute since it was established in 2008 and represents one of the largest federal research grants at the university.
"This award underscores the national significance of ACTRI’s work ...
Dr. Ji-Hyung Han’s research team from the Convergence Research Center of Sector Coupling & Integration at the Korea Institute of Energy Research (President Yi, Chang-Keun, hereinafter “KIER”) has developed a high-performance carbon cloth-based electrode that maintains stable performance even under high current conditions. The newly developed electrode is the first seawater electrolysis electrode using a carbon cloth support that has demonstrated successful continuous operation for over 800 hours under high current conditions, highlighting its potential for commercialization.
Water electrolysis is an ...
Traditional fossil fuels have low combustion efficiency and serious pollution, and the development of new energy conversion technologies such as wind energy and solar energy is limited by environmental conditions. As an efficient energy conversion device that directly converts chemical energy in fuel into electricity, solid oxide fuel cells (SOFCs) have attracted much attention due to their high efficiency, low emissions and strong fuel adaptability.
Although hydrogen is an ideal fuel for SOFC, its high storage and transportation limit its large-scale application. Due ...
A recent study from researchers at University of California San Diego is the first detailed assessment of companies offering school-based online surveillance services such as social media monitoring, student communications monitoring and online activity monitoring to middle and high schools. Schools pay for the services directly or may request federal grant funding to cover the costs.
Originally intended to support students’ mental health and prevent adverse school events, such as school shootings, ...
Determining whether a cancerous tumor originated in a given location or spread there from another tissue or organ in the body is important when assessing the likely course of a patient’s disease. When the origin of the primary tumor cannot be identified, it can be challenging to properly diagnose the malignancy and determine the best treatment strategy. Now, researchers at University of California San Diego have identified a microbial DNA signature in blood plasma that reliably differentiates primary liver cancer from colorectal cancer that has spread to the liver (metastatic colorectal cancer).
“The use of microbial DNA signatures could open up a new diagnostic pathway, ...
PULLMAN, Wash. –Researchers have long been able to use information from smartwatches to identify physical movement, such as sitting or walking, that wearers are performing in a controlled lab setting.
Now, Washington State University researchers have developed a way, using a computer algorithm and a large dataset gathered from smartwatches, to more comprehensively identify what people are doing in everyday settings, such as working, eating, doing hobbies or running errands.
The work, published in the IEEE Journal of Biomedical and Health Informatics, could someday lead ...
Los Angeles, CA – August 14, 2025 – The Terasaki Institute for Biomedical Innovation announces a significant advancement in addressing the fight against cancer-associated cachexia (CAC), a life-threatening syndrome responsible for over one-third of cancer-related deaths. Published in Cell, the study led by Dr. Aliesha O’Raw, Principal Investigator at the Institute, demonstrates that modulating the vagus nerve can effectively halt the progression of cachexia, enhance chemotherapy outcomes, and improve survival in preclinical models.
The study, titled “Vagal Blockade of the Brain-Liver Axis Deters Cancer-Associated Cachexia,” ...
AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by researchers led by Radboud university medical center in a study published in The Lancet Digital Health. The use of AI could reduce workload and save millions of euros annually.
Previous research in Sweden had already shown that AI detects breast cancer on mammograms more frequently than radiologists. Moreover, AI can reduce the workload for radiologists. Now, it appears that AI can also replace the second radiologist in the Dutch breast cancer screening program. This ...
High levels of triglycerides, the most common type of fat in the body and the foods we eat, directly cause abdominal aortic aneurysms, according to a study in mouse models led by Michigan Medicine.
Researchers identified triglyceride-rich lipoproteins and proteins that regulate triglyceride metabolism, including APOC3 and ANGPTL3, as causal drivers of abdominal aortic aneurysm.
The study challenges the longstanding belief that triglycerides are merely biomarkers of vascular disease and instead demonstrates that they play a direct and pathogenic role in aneurysm development, ...
A procedure performed under mild sedation in less than two hours by an interventional radiologist relieves chronic knee pain caused by osteoarthritis, an NYU Langone Health study shows.
As they gradually break down, knee joints in people with osteoarthritis are known to become inflamed, which triggers the growth of small blood vessels (angiogenesis) and increased blood flow to joints. The study procedure, called genicular artery embolization, kept this abnormal blood flow from ferrying in immune cells that cause the inflammation and related pain.
For the new study, the researchers delivered chemical beads (biocompatible hydrogels) ...
